Evidence map›Paper›PMID 28946872›Full record

ArticleLipids in health and disease2017

Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.

Yueru Li, Yinghui Rong, Lisui Bao, Ben Nie, Guang Ren, Chen Zheng, Rajesh Amin, Robert D Arnold, Ramesh B Jeganathan, Kevin W Huggins

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Journal of enzyme inhibition and medicinal chemistry · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Effect of Thai Herbal Remedy NL Inhibits Lipid Accumulation on 3T3-L1 Adipocyte Cells.Advances in pharmacological and pharmaceutical sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Identification ofiScience · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yueru LiDepartment of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, USA.
Yinghui RongDepartment of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, USA.
Lisui BaoDepartment of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, USA.
Ben NieDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
Guang RenDepartment of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, USA.
Chen ZhengDepartment of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, USA.
Rajesh AminDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
Robert D ArnoldDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
Ramesh B JeganathanDepartment of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, USA.
Kevin W HugginsDepartment of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, USA. huggikw@auburn.edu.
Auburn University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncreased consumption of omega-3 (ω-3) fatty acids found in cold-water fish and fish oil has been reported to protect against obesity. A potential mechanism may be through reduction in adipocyte differentiation. Stearidonic acid (SDA), a plant-based ω-3 fatty acid, has been targeted as a potential surrogate for fish-based fatty acids; however, its role in adipocyte differentiation is unknown. This study was designed to evaluate the effects of SDA on adipocyte differentiation in 3T3-L1 cells.

methods3T3-L1 preadipocytes were differentiated in the presence of SDA or vehicle-control. Cell viability assay was conducted to determine potential toxicity of SDA. Lipid accumulation was measured by Oil Red O staining and triglyceride (TG) quantification in differentiated 3T3-L1 adipocytes. Adipocyte differentiation was evaluated by adipogenic transcription factors and lipid accumulation gene expression by quantitative real-time polymerase chain reaction (qRT-PCR). Fatty acid analysis was conducted by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS).

results3T3-L1 cells treated with SDA were viable at concentrations used for all studies. SDA treatment reduced lipid accumulation in 3T3-L1 adipocytes. This anti-adipogenic effect by SDA was a result of down-regulation of mRNA levels of the adipogenic transcription factors CCAAT/enhancer-binding proteins alpha and beta (C/EBPα, C/EBPβ), peroxisome proliferator-activated receptor gamma (PPARγ), and sterol-regulatory element binding protein-1c (SREBP-1c). SDA treatment resulted in decreased expression of the lipid accumulation genes adipocyte fatty-acid binding protein (AP2), fatty acid synthase (FAS), stearoyl-CoA desaturase (SCD-1), lipoprotein lipase (LPL), glucose transporter 4 (GLUT4) and phosphoenolpyruvate carboxykinase (PEPCK). The transcriptional activity of PPARγ was found to be decreased with SDA treatment. SDA treatment led to significant EPA enrichment in 3T3-L1 adipocytes compared to vehicle-control.

conclusionThese results demonstrated that SDA can suppress adipocyte differentiation and lipid accumulation in 3T3-L1 cells through down-regulation of adipogenic transcription factors and genes associated with lipid accumulation. This study suggests the use of SDA as a dietary treatment for obesity.

Indexed as

3T3-L1 CellsAdipocytesAnimalsCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCell DifferentiationCell SurvivalFatty Acid-Binding ProteinsFatty Acids, Omega-3Fatty Acid Synthase, Type IGene Expression RegulationGlucose Transporter Type 4Lipid MetabolismLipoprotein LipaseMicePhosphoenolpyruvate Carboxykinase (ATP)CCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseCebpb protein, mouseFabp2 protein, mouseFabp4 protein, mouseFatty Acid-Binding ProteinsFatty Acids, Omega-3Fatty Acid Synthase, Type IGlucose Transporter Type 4Lipoprotein LipasePhosphoenolpyruvate Carboxykinase (ATP)PPAR gammaSlc2a4 protein, mouseSrebf1 protein, mousestearidonic acidStearoyl-CoA DesaturaseSterol Regulatory Element Binding Protein 13T3-L1Adipocyte differentiationObesityOmega-3 fatty acidsStearidonic acid

Identifiers

PMID28946872
PMCPMC5613458
OpenAlexW2760446596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.